Clinical Trial Update: Study of ONO-4578 and XELOX/FOLFOX Plus Bevacizumab in Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating ONO-4578 with XELOX or FOLFOX chemotherapy plus bevacizumab in colorectal cancer. The study is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• Leucovorin (folinic acid)
• ONO-4578
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Colorectal Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING